Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-084774
Filing Date
2026-07-17
Accepted
2026-07-17 21:54:51
Documents
1
Period of Report
2026-07-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2620763-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2620763-1_4seq1.xml 4 4375
  Complete submission text file 0001104659-26-084774.txt   6143
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Bisaro Paul (Reporting) CIK: 0001237253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 261185040

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Keenova Therapeutics plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)